Sheets Smith Wealth Management Bristol Myers Squibb CO Transaction History

Sheets Smith Wealth Management

$807 Million
Q3 2024

A detailed history of Sheets Smith Wealth Management transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Sheets Smith Wealth Management holds 5,188 shares of BMY stock, worth $299,243. This represents 0.03% of its overall portfolio holdings.

Number of Shares

5,188

Previous 5,427 4.4%

Holding current value

$299,243

Previous $225,000 19.11%

% of portfolio

0.03%

Previous 0.03%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$39.66 - $51.75 $9,478 - $12,368	-239 Reduced 4.4%	5,188 $268,000
Q2 2024 Jul 30, 2024	SELL	$40.25 - $52.99 $1.43 Million - $1.88 Million	-35,474 Reduced 86.73%	5,427 $225,000
Q1 2024 May 08, 2024	SELL	$47.98 - $54.4 $1.01 Million - $1.15 Million	-21,107 Reduced 34.04%	40,901 $2.22 Million
Q4 2023 Feb 06, 2024	BUY	$48.48 - $57.85 $92,936 - $110,898	1,917 Added 3.19%	62,008 $3.18 Million
Q3 2023 Oct 23, 2023	SELL	$57.89 - $64.73 $106,922 - $119,556	-1,847 Reduced 2.98%	60,091 $3.49 Million
Q2 2023 Aug 09, 2023	SELL	$63.71 - $70.74 $2,930 - $3,254	-46 Reduced 0.07%	61,938 $3.96 Million
Q1 2023 May 26, 2023	BUY	$65.71 - $74.53 $4.07 Million - $4.61 Million	61,915 Added 89731.88%	61,984 $4.3 Million
Q1 2023 May 12, 2023	SELL	$65.71 - $74.53 $4.05 Million - $4.59 Million	-61,599 Reduced 99.89%	69 $4,000
Q4 2022 Mar 08, 2023	BUY	$68.48 - $81.09 $17,804 - $21,083	260 Added 0.42%	61,668 $4.44 Million
Q3 2022 Nov 01, 2022	BUY	$0.13 - $76.84 $11 - $6,915	90 Added 0.15%	61,408 $4.37 Million
Q2 2022 Jul 27, 2022	SELL	$72.62 - $79.98 $72,547 - $79,900	-999 Reduced 1.6%	61,318 $4.72 Million
Q1 2022 May 02, 2022	SELL	$61.48 - $73.72 $364,760 - $437,380	-5,933 Reduced 8.69%	62,317 $4.55 Million
Q4 2021 Jan 20, 2022	SELL	$53.63 - $62.52 $953,702 - $1.11 Million	-17,783 Reduced 20.67%	68,250 $4.26 Million
Q2 2021 Aug 03, 2021	BUY	$61.91 - $67.42 $30,335 - $33,035	490 Added 0.57%	86,033 $5.75 Million
Q1 2021 Apr 23, 2021	BUY	$59.34 - $66.74 $4.71 Million - $5.3 Million	79,415 Added 1295.94%	85,543 $5.4 Million
Q4 2020 Jan 13, 2021	SELL	$57.74 - $65.43 $598,013 - $677,658	-10,357 Reduced 62.83%	6,128 $380,000
Q3 2020 Oct 26, 2020	BUY	$57.43 - $63.64 $592,562 - $656,637	10,318 Added 167.31%	16,485 $994,000
Q2 2020 Jul 17, 2020	SELL	$54.82 - $64.09 $760,298 - $888,864	-13,869 Reduced 69.22%	6,167 $363,000
Q1 2020 Apr 28, 2020	SELL	$46.4 - $67.43 $256,406 - $372,618	-5,526 Reduced 21.62%	20,036 $1.12 Million
Q4 2019 Jan 24, 2020	BUY	$49.21 - $64.19 $1.26 Million - $1.64 Million	25,562 New	25,562 $1.63 Million
Q1 2019 May 13, 2019	SELL	$45.12 - $53.8 $681,312 - $812,380	-15,100 Closed	0 $0
Q2 2018 Jul 26, 2018	SELL	$50.53 - $62.98 $52,500 - $65,436	-1,039 Reduced 6.44%	15,100 $836,000
Q3 2017 Oct 12, 2017	BUY	$55.23 - $63.74 $891,356 - $1.03 Million	16,139	16,139 $1.03 Million

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sheets Smith Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Sheets Smith Wealth Management with notifications on news.

Account

Sheets Smith Wealth Management Bristol Myers Squibb CO Transaction History